
    
      Randomized, prospective, monocentric, open-label comparative study with two parallel groups
      (Enoxaparin, at a preventive dose, combined with Aspirin versus Aspirin alone), with the main
      objective being to evaluate the effectiveness of enoxaparin, at a preventive dose, in
      reducing placental insufficiency during pregnancy in pregnant women.
    
  